GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Retractable Technologies Inc (AMEX:RVP) » Definitions » Asset Turnover

Retractable Technologies (Retractable Technologies) Asset Turnover : 0.08 (As of Dec. 2023)


View and export this data going back to 2001. Start your Free Trial

What is Retractable Technologies Asset Turnover?

Asset Turnover measures how quickly a company turns over its asset through sales. It is calculated as Revenue divided by Total Assets. Retractable Technologies's Revenue for the three months ended in Dec. 2023 was $14.29 Mil. Retractable Technologies's Total Assets for the quarter that ended in Dec. 2023 was $180.59 Mil. Therefore, Retractable Technologies's Asset Turnover for the quarter that ended in Dec. 2023 was 0.08.

Asset Turnover is linked to ROE % through Du Pont Formula. Retractable Technologies's annualized ROE % for the quarter that ended in Dec. 2023 was -0.29%. It is also linked to ROA % through Du Pont Formula. Retractable Technologies's annualized ROA % for the quarter that ended in Dec. 2023 was -0.16%.


Retractable Technologies Asset Turnover Historical Data

The historical data trend for Retractable Technologies's Asset Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Retractable Technologies Asset Turnover Chart

Retractable Technologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Asset Turnover
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.10 1.14 1.21 0.47 0.23

Retractable Technologies Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Asset Turnover Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.06 0.06 0.04 0.06 0.08

Competitive Comparison of Retractable Technologies's Asset Turnover

For the Medical Instruments & Supplies subindustry, Retractable Technologies's Asset Turnover, along with its competitors' market caps and Asset Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Retractable Technologies's Asset Turnover Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Retractable Technologies's Asset Turnover distribution charts can be found below:

* The bar in red indicates where Retractable Technologies's Asset Turnover falls into.



Retractable Technologies Asset Turnover Calculation

Asset Turnover measures how quickly a company turns over its asset through sales.

Retractable Technologies's Asset Turnover for the fiscal year that ended in Dec. 2023 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (A: Dec. 2023 )/( (Total Assets (A: Dec. 2022 )+Total Assets (A: Dec. 2023 ))/ count )
=43.597/( (195.666+179.672)/ 2 )
=43.597/187.669
=0.23

Retractable Technologies's Asset Turnover for the quarter that ended in Dec. 2023 is calculated as

Asset Turnover
=Revenue/Average Total Assets
=Revenue (Q: Dec. 2023 )/( (Total Assets (Q: Sep. 2023 )+Total Assets (Q: Dec. 2023 ))/ count )
=14.29/( (181.516+179.672)/ 2 )
=14.29/180.594
=0.08

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Companies with low profit margins tend to have high Asset Turnover, while those with high profit margins have low Asset Turnover. Companies in the retail industry tend to have a very high turnover ratio.


Retractable Technologies  (AMEX:RVP) Asset Turnover Explanation

Asset Turnover is linked to ROE % through Du Pont Formula.

Retractable Technologies's annulized ROE % for the quarter that ended in Dec. 2023 is

ROE %**(Q: Dec. 2023 )
=Net Income/Total Stockholders Equity
=-0.292/99.356
=(Net Income / Revenue)*(Revenue / Total Assets)*(Total Assets / Total Stockholders Equity)
=(-0.292 / 57.16)*(57.16 / 180.594)*(180.594/ 99.356)
=Net Margin %*Asset Turnover*Equity Multiplier
=-0.51 %*0.3165*1.8176
=ROA %*Equity Multiplier
=-0.16 %*1.8176
=-0.29 %

Note: The Net Income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** The ROE % used above is for Du Pont Analysis only. It is different from the defined ROE % page on our website, as here it uses Net Income instead of Net Income attributable to Common Stockholders in the calculation.

It is also linked to ROA % through Du Pont Formula:

Retractable Technologies's annulized ROA % for the quarter that ended in Dec. 2023 is

ROA %(Q: Dec. 2023 )
=Net Income/Total Assets
=-0.292/180.594
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-0.292 / 57.16)*(57.16 / 180.594)
=Net Margin %*Asset Turnover
=-0.51 %*0.3165
=-0.16 %

Note: The Net Income data used here is four times the quarterly (Dec. 2023) net income data. The Revenue data used here is four times the quarterly (Dec. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

In the article Joining The Dark Side: Pirates, Spies and Short Sellers, James Montier reported that In their US sample covering the period 1968-2003, Cooper et al find that firms with low asset growth outperformed firms with high asset growth by an astounding 20% p.a. equally weighted. Even when controlling for market, size and style, low asset growth firms outperformed high asset growth firms by 13% p.a. Therefore a company with fast asset growth may underperform.

Therefore, it is a good sign if a company's Asset Turnover is consistent or even increases. If a company's asset grows faster than sales, its Asset Turnover will decline, which can be a warning sign.


Retractable Technologies Asset Turnover Related Terms

Thank you for viewing the detailed overview of Retractable Technologies's Asset Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.


Retractable Technologies (Retractable Technologies) Business Description

Traded in Other Exchanges
N/A
Address
511 Lobo Lane, Little Elm, TX, USA, 75068-5295
Retractable Technologies Inc designs, develops, manufactures, and markets safety syringes and other safety medical products for the healthcare profession. The company's products are the VanishPoint 0.5mL insulin syringe; 1mL tuberculin, insulin, and allergy antigen syringes; 0.5mL, 1mL, 2mL, 3mL, 5mL, and 10mL syringes; the small diameter tube adapter; the blood collection tube holder; the allergy tray; the IV safety catheter; the Patient Safe syringes; the Patient Safe Luer Cap; the VanishPoint Blood Collection Set; and the EasyPoint needle, as well as a standard 3mL syringe packaged with an EasyPoint needle. The company also sells VanishPoint autodisable syringes in the international market in addition to its other products.
Executives
Thomas J Shaw director, 10 percent owner, officer: President and CEO 511 LOBO LANE, LITTLE ELM TX 75068
Braden Michael Leonard 10 percent owner 156 S. FIRST STREET, ZIONSVILLE IN 46077
Bigby Walter O Jr director 816 BENTON RD, BOSSIER CITY LA 71111
Darren E Findley director 1618 GRASSMERE RD, FRANKLIN TN 37064
Russell B Kuhlman director, officer: Vice President of Sales 511 LOBO LANE, PO BOX 9, LITTLE ELM TX 75068
Fort John W Iii director, officer: Chief Financial Officer 511 LOBO LANE, LITTLE ELM TX 75068
Amy Mack director 1701 LEGACY DRIVE SUITE 100, FRISCO TX 75034
Clarence D Zierhut director 1217 BLUEBIRD LANE, GARLAND TX 75042
Lillian E Salerno 10 percent owner 777 7TH AVENUE, UNIT 308, WASHINGTON DC 20001
Suzanne M August 10 percent owner 340 NORTH JULIA CIRCLE, ST. PETERSBURG FL 33706
Steven R Wisner director, officer: Exec. VP, Eng & Prod. 511 LOBO LANE, PO BOX 9, LITTLE ELM TX 75068
Marco Laterza director P.O. BOX 64104, EL PASO TX 79904
Jimmie Shiu director 511 LOBO LANE, P.O. BOX 9, LITTLE ELM TX 75068
Patti King director 9145 MARTIN ROAD, ROSWELL GA 30076
Michele Larios officer: Vice President/General Counsel 511 LOBO LANE, LITTLE ELM TX 75068

Retractable Technologies (Retractable Technologies) Headlines